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Abstract 
Background: Although next generation sequencing (NGS) offers the potential for studying virus populations in 
unprecedented depth, PCR error, amplification bias and recombination during library construction have limited its 
use to population sequencing and measurements of unlinked allele frequencies. Here we report a method, termed 
ultrasensitive Single-Genome Sequencing (uSGS), for NGS library construction and analysis that eliminates PCR errors 
and recombinants, and generates single-genome sequences of the same quality as the “gold-standard” of HIV-1 
single-genome sequencing assay but with more than 100-fold greater depth.
Results: Primer ID tagged cDNA was synthesized from mixtures of cloned BH10 wild-type and mutant HIV-1 
transcripts containing ten drug resistance mutations. First, the resultant cDNA was divided and NGS libraries were 
generated in parallel using two methods: uSGS and a method applying long PCR primers to attach the NGS adaptors 
(LP-PCR-1). Second, cDNA was divided and NGS libraries were generated in parallel comparing 3 methods: uSGS and 2 
methods adapted from more recent reports using variations of the long PCR primers to attach the adaptors (LP-PCR-2 
and LP-PCR-3). Consistently, the uSGS method amplified a greater proportion of cDNAs, averaging 30% compared 
to 13% for LP-PCR-1, 21% for LP-PCR-2 and 14% for LP-PCR-3. Most importantly, when the uSGS sequences were 
binned according to their primer IDs, 94% of the bins did not contain PCR recombinant sequences versus only 55, 75 
and 65% for LP-PCR-1, 2 and 3, respectively. Finally, when uSGS was applied to plasma samples from HIV-1 infected 
donors, both frequent and rare variants were detected in each sample and neighbor-joining trees revealed clusters of 
genomes driven by the linkage of these mutations, showing the lack of PCR recombinants in the datasets.
Conclusions: The uSGS assay can be used for accurate detection of rare variants and for identifying linkage of rare 
alleles associated with HIV-1 drug resistance. In addition, the method allows accurate in-depth analyses of the com-
plex genetic relationships of viral populations in vivo.
Keywords: HIV, Single-genome sequencing, SGS, Primer ID, Supermajority correction, Allele linkage, Targeted next-
generation sequencing, NGS, Deep sequencing, Minority variants, HIV drug resistance
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Background
Next generation sequencing (NGS) has the potential to 
become a powerful tool for studying the genetics of viral 
RNA populations from cDNA libraries generated by 
RT-PCR. To date, its application to targeted sequencing 
of diverse HIV-1 or other viral RNA populations has been 
limited by PCR error, unequal amplification of sequences 
(PCR bias), and PCR recombination during library con-
struction. It is known that polymerase mis-incorporation 
errors accumulate during PCR [1–4] requiring the use 
of sophisticated statistical algorithms of variable accu-
racy [5–7] to distinguish errors from actual genetic poly-
morphisms. PCR bias occurs by selective or preferential 
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amplification of some templates over others, limiting 
and misrepresenting the number of original distinct viral 
RNA templates represented in the final sequencing data 
[1–4]. Most importantly, PCR-mediated recombination 
can rearrange the sequences among amplicons produc-
ing variants or haplotypes that are not actually present 
in vivo [2, 8, 9], and causing the loss of rare haplotypes 
through recombination between amplicons with wildtype 
alleles that dominant the PCR reaction. As such, PCR 
recombination not only skews population frequencies, 
but also limits the ability to detect linkage among rare 
genetic polymorphisms. Together, these problems have 
restricted the applicability of NGS for genetic analysis of 
HIV-1 or other viral populations causing it to fall short 
of replacing the “gold standard” of HIV-1 single-genome 
sequencing (SGS), which virtually eliminates PCR error, 
bias, and recombination but is constrained by the limited 
number of sequences that can be obtained easily [10–14].
To help address these issues, primer IDs, consisting of 
molecular tags comprising 4–10 degenerate nucleotides 
(nt), have been incorporated into RT primers so that 
each cDNA molecule generated by reverse transcription 
is uniquely labeled [1, 15–18]. Primer ID-tagged cDNAs 
are then replicated by PCR and daughter amplicons are 
sequenced by NGS. Next, binning sequence reads by 
their common primer IDs reveals PCR template resa-
mpling. In addition, the alignment of binned sequences 
facilitates the identification of PCR errors and PCR 
recombination such that one consensus sequence can be 
generated that is devoid of such artifacts. Although mis-
incorporation errors within the primer ID itself during 
PCR can give misleading results, filtering techniques can 
be used to detect and exclude primer IDs with mis-incor-
porations [19]. As such, primer IDs are extremely effec-
tive in identifying errors introduced during NGS library 
generation and are the only means by which the number 
of amplified templates can be accurately determined; 
and, consequently, allele frequencies in HIV-1 RNA pop-
ulations accurately measured.
During library generation, NGS requires the attach-
ment of adaptor sequences for library capture, local 
amplification, and sequencing. Current methods to 
attach these adaptors employ PCR primers of varied 
length, ranging from 55 [19, 20] to as long as 92 nucleo-
tides [21]. In addition, two [19] or three rounds of flank-
ing PCR [20] are used to attached the requisite adaptors. 
One such “long primer PCR” method (LP-PCR-1) has 
been shown to produce very high levels of PCR recom-
bination [21] such that the final results are unreliable 
for identifying rare mutations or for performing accu-
rate analyses of population genetics. Newer methods for 
long primer PCR (LP-PCR-2 and LP-PCR-3) [19, 20] are 
improvements over LP-PCR 1, but as shown here, these 
methods can still cause loss of variants either due to PCR 
bias, error, and/or recombination. Accordingly, we devel-
oped a new method for NGS library construction called 
ultrasensitive single-genome sequencing (uSGS), which 
uses a unique method to attach the NGS adaptors to 
amplified templates that does not require additional PCR. 
The method combines limited-cycle PCR with a highly 
efficient method of adapter ligation. The uSGS method 
also amplifies a higher fraction of cDNA molecules than 
the LP-PCR methods, and significantly reduces the per-
centage of sequences that are lost from PCR errors and 
recombination. Data resulting from uSGS rivals the accu-
racy and reliability of the “gold standard” HIV-1 SGS 
assay (sometimes referred to as single genome amplifica-
tion [SGA] and sequencing) but with more than 100-fold 
greater sequencing depth.
Here, we report a comparative analysis of uSGS and 
methods adapted from recent reports [2, 19–21] for tar-
geted NGS library generation and show that uSGS is a 
superior method for generating NGS datasets free of PCR 
error, and recombination. Although uSGS is described 
here for its utility in studying HIV-1 RNA populations, 
it can be easily modified to investigate other viral RNA 
populations as well as transcript sequences across cell 
types, including malignant cells.
Experimental design
Primer ID-tagged cDNAs were prepared from mixtures 
of wild-type (WT) and mutant transcripts derived from 
cloned BH10 HIV pol DNA. The mutant transcripts 
contained 10 well-characterized, HIV-1 drug resistance 
mutations rendering them useful for measuring recombi-
nation and allele frequencies. In our initial experiments, 
the cDNA was divided and amplified with 2 different 
methods, uSGS (Fig.  1a) and LP-PCR-1 (Fig.  1b). uSGS 
was performed with short (25-31nt) primers containing 
4 or 5 deoxyuridine (dU) residues. The amplified prod-
ucts were subsequently treated with uracil DNA glyco-
sylase (UDG) and alkali, leaving  ~17nt single-stranded 
tails, permitting efficient directional ligation [22, 23] of 
Illumina adaptor sequences. LP-PCR 1 used long (93nt) 
primers to incorporate Illumina adaptor sequences in a 
single round of PCR. In subsequent experiments, the 
primer ID-tagged cDNAs mixtures were divided 3-ways 
and amplified by uSGS (Fig. 1a) or by LP-PCR-2 (Fig. 1c) 
and LP-PCR-3 (Fig.  1d), the latter two methods requir-
ing 55–65nt primers to incorporate Illumina adapters. 
LP-PCR-2 and 3 were performed using the reagents and 
conditions specified in the original publications [19, 
20]. LP-PCR-2 required 2 rounds of PCR and LP-PCR-3 
required 3 rounds. NGS libraries prepared by all meth-
ods were sequenced using paired-end MiSeq technol-
ogy and raw sequencing reads were processed through 
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Fig. 1 Schematic representation of the methods used for NGS library construction. A cDNA library labeled with Primer IDs (top) is divided and used 
for each method. a uSGS. Short PCR primers (25 and 31 bases) containing 5′ dU in place of dT residues (dots in the primers) are used to amplify the 
cDNA. Products are cleaved at the dU sites creating dsDNA with 17-nt 3′-overhangs at both ends. The ends are then ligated to the essential NGS 
adapters and filled out using Klenow Fragment DNA polymerase to generate a fully double-stranded NGS library. b Long primer PCR-1. Long prim-
ers (90 and 93nt) containing NGS adapter sequences are used to amplify the cDNA library. c Long primer PCR-2. Relatively long primers (50–61nt) 
are used in 2 rounds of flanking PCR to amplify the cDNA and attach the adaptors. d Long primer PCR-3 involves 3 rounds of PCR. The cDNA is 
amplified with short primers (25 and 31 bases) followed by 2 rounds of flanking PCR using long primers (50–61nt) to attach the adaptors
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the analytical pipeline described in Methods. Briefly, 
sequence reads from samples were separated accord-
ing to their indexes and binned by common primer IDs. 
“Super-consensus” sequences were built from “qualified” 
unique primer ID groups resulting in a single-genome 
sequence per primer ID. To be qualified, a “super-con-
sensus” sequence required two characteristics. First, it 
had to be derived from a set of common primer IDs that 
satisfied the cutoff model designed by Zhou et  al. [19]. 
Zhou et al. [19] showed that low abundance primer IDs 
or “offspring” were artifacts resulting from PCR errors 
within the primer ID. To ensure that these artifacts were 
eliminated from the data, a cutoff model was designed for 
the minimum number of raw sequence reads required to 
make a consensus sequence. Second, we required “super-
majorities” of ≥80% identity at each nucleotide position 
for a “super-consensus” sequence to be included in the 
dataset. We found that a simple majority (i.e., >50% con-
sensus at each nucleotide position) does not eliminate 
artifacts resulting from early-cycle PCR recombination 
or other PCR errors. In a simple majority, only late cycle 
PCR errors or late cycle recombinant events are elimi-
nated. Accordingly, we increased the stringency of our 
filtering so that a “supermajority” of ≥80% identical bases 
at each nucleotide position would eliminate early PCR 
cycle errors and recombinants. To illustrate our findings, 
we analyzed the mixtures of WT and mutant transcripts 
at majority cutoffs of 50–100% for the 10 HIV-1 drug 
resistance sites for each of the methods. Accordingly, if 
a final consensus sequence had a site of ambiguity, the 
sequence was discarded because this sequence contained 
either a PCR mis-incorporation error or a mixture of 
calls at the same site due to PCR recombination (or rare 
use of the same primer ID more than once). Final data-
sets for all the approaches were analyzed to compare (1) 
the fraction of the total cDNA molecules amplified effi-
ciently, (2) the frequency of PCR/sequencing errors, (3) 
the level of PCR-based recombination, and (4) the sensi-
tivity for detection of rare alleles.
Results
PCR efficiency, and template sampling
First, we compared amplification efficiency result-
ing from 3 independent experiments in which a sin-
gle preparation of cDNA was synthesized using primer 
IDs, divided and used to compare the LP-PCR-1 and 
uSGS methods for NGS library generation. Table  1 tal-
lies the average number of unique primer IDs contain-
ing the qualified number of raw sequences above the 
cutoff as defined by Zhou et al. [19]. The % cDNA ampli-
fied was calculated by dividing the number of consensus 
sequences above the cutoff by the number of starting 
copies as measured by qPCR, with averaging over 3 
experiments. As shown in Table 1A, uSGS yielded more 
total unique primer IDs and more than twice as many 
consensus sequences compared to LP-PCR-1 (30 vs. 13% 
of starting cDNAs, respectively). To further assess which 
method of library construction provided more complete 
sampling of the viral population, libraries were synthe-
sized in 3 more replicate experiments in which a prepara-
tion of primer ID-tagged cDNA was divided into thirds 
and used to compare LP-PCR-2, LP-PCR-3, and uSGS 
methods (Table 1B). Ultrasensitive SGS generated greater 
than two-fold more consensus sequences than LP-PCR-3 
(31 vs. 14%) and 1.5-fold more sequences than LP-PCR-2 
(31 vs. 21%). 
Table 1 Comparison of cDNA amplification efficiency among methods using the same HIV-1 site specific RT-Primer ID primer
All results are taken from an average of 3 separate experimental libraries prepared from each method
a Total number of consensus sequences above the Zhou algorithm cutoff [19]
uSGS LP-PCR-1
AVG STDV AVG STDV
A.
 Copies of cDNA by qPCR 134,193 45,940 134,193 45,940
 Total # unique primer IDsa 39,597 7491 17,614 6442
 % cDNA amplified 30% 13% 13% 3.3%
uSGS LP-PCR-2 LP-PCR-3
AVG STDV AVG STDV AVG STDV
B.
 Copies of cDNA by qPCR 81,040 21,192 81,040 21,192 81,040 21,192
 Total # unique primer IDsa 25,111 9046 15,794 1392 11,565 482
 % cDNA amplified 31% 4.9% 21% 2.5% 14% 2.2%
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PCR and sequencing error rates
Binning raw sequence reads by primer ID, generating 
alignments, and producing “supermajority” sequences 
(≥80% agreement at each site) resulted in PCR/sequenc-
ing error rates approximately 10-fold lower than the 
uncorrected sequences regardless of the method used 
for generation of NGS libraries. Specifically, uncorrected 
PCR/sequencing error rates of 2.8 × 10−3 and 1.6 × 10−3 
were calculated for raw sequence reads generated by LP-
PCR-1,2,3 and uSGS, respectively, values consistent with 
other reports [2, 24]. After applying the Zhou et al. [19] 
consensus cutoff model and generating the supermajor-
ity sequences from the alignments of reads sharing com-
mon primer IDs, the PCR/sequencing error rates were 
reduced to 1 × 10−4 for uSGS, LP-PCR-1 and LP-PCR-3 
and to 2 × 10−4 for LP-PCR-2 (Table 2). These rates are 
comparable to those measured for standard SGS and 
the basal rate of 1 ×  10−4 mutations per base per cycle 
reported for HIV-1 reverse transcriptase in  vitro [25], 
indicating that PCR and sequencing errors were essen-
tially eliminated by the inclusion of primer IDs and the 
generation of supermajority sequences by our pipeline. 
Furthermore, in a separate experiment using 100% WT 
transcripts, we found that the PCR/sequencing error rate 
was approximately the same—5 × 10−5—at all sites in the 
500 base pair amplicons indicating that PCR/sequencing 
errors do not occur at higher rates at the drug resistance 
sites and that no false positive calls for drug resistance 
mutations occurred.
PCR-mediated recombination
Given that low frequency alleles can be missed and link-
age eliminated by PCR recombination, we assessed 
its extent using all 4 methodologies. Primer ID tagged 
cDNAs were generated from mixtures of mutant and WT 
BH10 HIV-1 pol transcripts and NGS libraries were pre-
pared. NGS libraries were sequenced, reads binned by 
primer ID, consensus cutoffs of >50, ≥60, ≥70, ≥80, ≥90 
Table 2 Comparison of Recombination between methods at different consensus majority cutoffs in mixtures of BH10 WT 
and mutant transcript RNA
a Consensus sequences were excluded due to failure to achieve the required majority at each level of consensus at each nucleotide position, likely due to in vitro PCR 
recombination
b Incorrect bases at non drug resistant sites
% Majority cutoff Method/
enzyme







50 uSGS 33,870 0.6 99.4 0.39 0.020
60 33,870 1.1 98.9 0.30 0.018
70 Kapa Hi Fi 33,870 2.6 97.4 0.20 0.015
80 Uracil+ 33,870 5.8 94.2 0.13 0.014
90 33,870 28.4 71.6 0.12 0.010
100 33,870 43.9 56.1 0.12 0.009
50 LP-PCR-1 11,008 4.7 95.3 4.07 0.033
60 11,008 11.7 88.3 1.86 0.030
70 Taq Gold 11,008 27.3 72.7 0.34 0.020
80 11,008 45.0 55.0 0.20 0.014
90 11,008 77.3 22.7 <0.01 0.007
100 11,008 87.2 12.8 <0.06 0.006
50 LP-PCR-2 23,142 1.4 98.6 0.91 0.037
60 23,142 3.3 96.7 0.62 0.033
70 Kapa2G 23,142 10.5 89.5 0.30 0.024
80 Robust 23,142 25.4 74.6 0.14 0.020
90 23,142 63.5 36.5 0.09 0.013
100 23,142 85.7 14.3 0.15 0.009
50 LP-PCR-3 20,252 4.6 95.4 6.44 0.016
60 20,252 13.8 86.2 2.00 0.015
70 Platinum 20,252 23.4 76.6 0.35 0.013
80 Hi Fi Taq 20,252 34.8 65.3 0.15 0.011
90 20,252 71.7 28.3 <0.04 0.004
100 20,252 92.0 8.0 <0.07 0.004
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and 100% majorities applied, and consensus sequences 
were generated from the survivors (Table 2) at each of the 
10 drug resistance sites. Where a mixture was detected 
at any position in a specific primer ID bin at less than 
the stated majority, that consensus sequence was elimi-
nated from consideration. The final data set was then 
analyzed for recombinants that were missed by the filter-
ing pipeline at the ten drug resistance sites and for incor-
rect bases at all non-drug resistant sites. As italicized in 
Table  2, uSGS at the  ≥80% supermajority achieved the 
most accurate data set resulting in an error rate equiva-
lent to that of RT in  vitro [25], while preserving 94.4% 
of the original cDNA sequences. By contrast, the other 
3 methods were able to achieve the same accuracy at 
the ≥80% supermajority cutoff but with a much greater 
cost to the number of final sequences, with reductions 
in the size of the final data set ranging from 25 to 45%. 
Because recombination only destroys linkage of alleles, 
detecting linkage among drug resistance sites would be 
hampered in libraries generated from clinical samples 
using LP-PCR-1, 2 or 3 given the in vitro recombination 
rates observed, whereas detection of such linked alleles 
would be much more likely in libraries generated using 
uSGS.
To further illustrate this finding, neighbor-joining (NJ) 
trees were generated for a random selection of 50 super-
majority consensus sequences produced from the mix-
tures sequenced using each method (Fig. 2). Also shown 
on the trees are the BH10 WT and mutant HIV-1 refer-
ence sequences. The orange circles represent sequences 
with mixtures of nucleotides at one or more of the 10 ten 
drug resistance sites, which failed to satisfy the superma-
jority requirement and therefore would be deleted from 
the dataset. In this random sampling, 50, 26 and 40% of 
the sequences would have been be omitted from the LP-
PCR-1, LP-PCR-2 and LP-PCR-3 datasets respectively 
compared to only 8% from the uSGS dataset.
Calculating allele frequencies
To compare the ability of all methods to accurately deter-
mine allele frequencies, cDNA libraries were obtained 
from mixtures of mutant RNA transcripts in a WT back-
ground from 10 to 1% for uSGS vs. LP-PCR-1 (Table 3a, 
b) and from mixtures of 30–0.3% for uSGS vs. LP-PCR-2 
and LP-PCR-3 (Table  3d, e). Each cDNA mixture was 
divided in half for the first comparison described above 
and in thirds for the second. To determine whether PCR 
recombination results in the loss of sensitivity for detec-
tion of individual alleles, consensus sequences where 
built from the  >50 and ≥80% supermajority of reads. 
Recombinants were retained for this analysis (Table  3). 
An obvious loss of mutant alleles toward the 5′ end of the 
transcripts was evident in the LP-PCR-1, 2, and 3 but not 
in the uSGS data (Table 3a–e). This loss of mutant alleles, 
most evident in the ≥80% majority cutoff (Table  3b, e), 
was likely due to premature DNA polymerase (or RT) ter-
mination followed by extension of the termination prod-
uct on the more abundant WT template during the early 
cycles of PCR in the LP-PCR-1,2,3 protocols. Consistent 
with this hypothesis, the allele frequencies in the raw 
sequence data from these methods (without generating 
consensus sequences) did not exhibit such bias (Table 3c) 
due to the fact that the individual alleles were still present 
regardless of whether they were in recombinant species 
or not.
Usage of different enzymes
To determine if the DNA polymerase used was the basis 
for the superior performance of uSGS compared to the 
other 3 methods, we conducted three parallel experi-
ments in which uSGS or LP-PCR-1 were used to gen-
erate NGS libraries from mixtures of WT and mutant 
RNAs while varying the DNA polymerase used. Ampli-
Taq Gold (used in LP-PCR-1), Kapa Uracil  +  DNA 
polymerase (used for uSGS) and Platinum Taq (used in 
LP-PCR-3) were compared (Table  4). For all compari-
sons, the uSGS method, regardless of the enzyme used, 
provided a more complete sampling of the viral popula-
tion, maintaining more of the starting cDNA represented 
in the final data set, as well as, retaining  ≥90% of the 
final sequences after PCR errors and recombinants were 
removed (Table 4). While the Kapa Uracil +enzyme is an 
important component of the uSGS reaction because of 
its ability to copy dU-containing templates, we suggest 
that the use of shorter primers and efficient ligation are 
more important for optimizing the performance of the 
method. Moreover, it cannot be presumed that using 
a polymerase with the highest reported fidelity would 
reduce the error rate in any PCR method because poly-
merase processivity (or lack thereof ), not fidelity, is the 
enzymatic property most likely to contribute to PCR 
recombination.
Comparison of uSGS to LP-PCR for analysis of a clinical 
sample
To compare the methods for clinical samples, NGS 
libraries were constructed using LP-PCR-1 and uSGS 
on primer ID-containing cDNA prepared from a 
plasma sample collected from an untreated, chroni-
cally HIV-1 infected donor. The product (~13,600 
copies of cDNA) was then divided in half for parallel 
library construction using LP-PCR-1 or uSGS. LP-
PCR and uSGS recovered 2091 and 2237 supermajor-
ity consensus sequences, respectively. Random subsets 
of 15 aligned supermajority sequences were selected 
to assess the extent of in  vitro recombination (Fig.  3). 
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Only 3 of the 15 supermajority sequences analyzed 
from the LP-PCR-1 method were found to accurately 
reflect their parent cDNA, with the 12 remaining 
sequences containing ambiguous base calls (shown 
as dashes) among the 72 nt positions represented in 
the figure. The ambiguous sites are in areas of higher 
Fig. 2 Neighbor joining trees comparing PCR recombination in each method. Neighbor joining trees rooted on NL4-3 generated from randomly 
selected sets of 50 supermajority sequences obtained from mixtures of WT and Mutant BH10 pol transcripts. Reference sequences for the BH10 
mutant and WT and NL4-3 WT are shown in large blue, black and green squares, respectively. Sequences matching the references are shown in the 
same colors as the references. The orange circles show an intermediate step in the bioinformatics computations and represent those sequences 
identified as PCR recombinant species that would be lost from the respective data sets after they were deleted in the final steps of the pipeline
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diversity in the sequence, suggesting that the sequences 
were PCR recombinants. By contrast, the uSGS method 
produced only a single ambiguous base indicating rare 
PCR recombination and the suitability of this approach 
for analyzing linkage and population structure after 
identifying and omitting such recombinants. After 
the filtering pipeline was applied to discard consensus 
sequences with  >2 ambiguous bases, uSGS preserved 
96% of the original cDNA sequences whereas the LP-
PCR-1 dataset preserved <40%.
Table 4 Comparison of different DNA polymerases for library preparation using LP-PCR-1 and uSGS
a Final number of “super majority” consensus sequences after removal of >2 ambiguous sites likely due to in vitro PCR recombination
b Synthesis of cDNA from WT/Mutant mixture of transcript HIV-1 RNA, divided into 4 parts and parallel libraries sequenced
c Synthesis of cDNA from WT/Mutant mixtures of transcript HIV-1 RNA independently in two separate experiments








34,094 11,215 40 6729 20
uSGS AmpliTaq
Goldb
34,094 11,859 7 11,060 32
LP-PCR-1 Kapa
Uracil+b
34,094 3566 11 3188 9
uSGS Kapa
Uracil+b
34,094 18,855 2 18,512 54
LP-PCR-1 Platinum
Taqc
14,410 2789 82 558 4
uSGS Platinum
Taqc
88,560 25,773 10 22,938 26
Fig. 3 Snapshot of sequence alignments of library construction obtained from clinical sample. Small subsets of supermajority sequence alignments 
obtained from a donor sample using the (a) LP-PCR or (b) uSGS methods of NGS library construction. Dashes (“–” in red) which have been placed in 
the consensus sequences by the bioinformatics pipeline in positions with <80% identity in sequences in a given daughter set, which is indicative of 
recombination during PCR. Asterisks mark positions with diverse bases in the uSGS data where no PCR recombination is seen
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Application of uSGS to clinical samples
To assess the robustness and sensitivity of the uSGS 
assay, we applied the assay using 1  ml from each of 3 
plasma samples with viral loads of 5000–10,000 copies/
ml from two HIV-infected donors on failing antiretrovi-
ral therapy. uSGS data were assessed for unique linkage 
among HIV-1 drug resistant variants and for popula-
tion structure using neighbor-joining (NJ) trees (Table 6; 
Fig. 4), which allow visualization of the alignments with-
out imposing any evolutionary assumptions on the rela-
tionships between sequences.
Of the 3470 total consensus sequences from all 3 sam-
ples, an average of 1% were lost to analysis due to  >2 
ambiguous bases from in  vitro recombination, resulting 
in 677–1577 final sequences per sample, or 30–80 fold 
more sequences than are customary for standard SGS 
(usually 20–50 sequences). The NJ tree of the sequences 
from donor 1 (Fig. 4) revealed clusters of resistant vari-
ants on multiple independent nodes. Within these clus-
ters, rare HIV-1 variants (haplotypes) were detected in 
each sample. For example, in the sample from patient 1 
(sample 1), the frequencies of RT codons 106  V (WT), 
101Q and 108I (mutants) were approximately 9, 4 and 
0.5%, respectively (Table  5). If one assumes that these 
frequencies are mutually independent, the expected 
frequency of the haplotype containing all three alleles 
is  ~0.002% (Table  6). However, we found that the fre-
quency of the 101Q/106V/108I haplotype was 0.13% 
(Table 6 and expanded section of NJ tree in Fig. 4), sig-
nificantly different (p  =  0.0004) from the expected fre-
quency. In addition, 4 of the 5 haplotypes containing 
106 V in the cluster were present at significantly higher 
frequencies than expected from mutual independence 
(p = <1.0 × 10−237 to 0.004; Table 6). These results imply 
that the clustering of alleles observed in the neighbor 
joining analyses (Fig. 4) could not have arisen by chance 
reshuffling during PCR and therefore accurately repre-
sent the HIV-1 population in vivo.
Discussion
SGS was originally developed to circumvent errors 
inherent in earlier methods of analysis of the genetic 
structure of viral populations, including PCR induced 
mutation and recombination, as well as resampling of 
the same templates. NGS is being increasingly utilized 
by researchers for the same purpose, and offers signifi-
cant advantages over SGS in expense and throughput. 
However, in its simplest form this new technology is sub-
ject to the same errors—mutation, recombination, and 
resampling—that SGS was designed to prevent. Great 
care must be taken to ensure that errors introduced by 
the method of library construction are minimized, and 
are not falsely interpreted as being characteristic of the 
population being analyzed. Methods (e.g. Nextera [26]) 
that do not permit the targeted identification of indi-
vidual molecules or determination of the numbers of 
cDNA molecules that have been synthesized, amplified, 
and sequenced cannot be used to accurately reconstruct 
intrapatient population structure or genetic relation-
ships of viral RNA or DNA populations. As described 
here and in recent studies, the use of primer IDs using 
different methods of library preparation and analysis to 
track each molecule and its amplified progeny during 
NGS library construction has helped to resolve this prob-
lem [2, 19, 20, 27]. However, the methods used to date 
to generate such targeted libraries remain subject to early 
cycle PCR-recombination and or early cycle PCR error 
resulting in sequence data that may not be entirely accu-
rate and could have the potential to miss low frequency 
alleles. In fact, we observed a decrease in the sensitiv-
ity of detecting some mutant alleles toward the 5′ end 
of the transcript using the LP-PCR-1, 2 and 3 method-
ologies. The striking 5′ to 3′ bias, likely reflects small 
amounts of premature termination products in the initial 
cDNA (i.e. truncated cDNAs). Since the same cDNA was 
used for all the analyses, the bias most likely arises from 
reduced priming efficiency of the extended primers used 
in the LP protocols relative to that of our short primers 
or the truncated cDNA sequences. In the first PCR cycle, 
the completed cDNA products will be copied into plus 
strands, which will in turn be copied initiating on to the 
added primer or the 3′ truncated cDNA. The frequency 
of 5′ biased recombination in this step will be a func-
tion of the relative priming efficiency of the two primers 
(truncated cDNA vs. reverse LP primer). We hypoth-
esize that the non-complementary 5′ extensions (index 
and adaptor sequence) of the LPs greatly reduces their 
efficiency in the second cycle (relative to the truncated 
cDNAs), when only a small 3′ portion of the LP primer is 
paired with the 3′ end of the first cycle product, allowing 
recombinant products primed by the truncated cDNAs 
to predominate. Since the truncated cDNAs will prime 
randomly on the first cycle products, this effect will cause 
5′–3′ biased loss of minority alleles in the final PCR prod-
ucts. Consistent with this concept, when allele frequen-
cies were determined using the raw sequence data, no 
bias was encountered because all individual alleles were 
counted irrespective of recombination. However, with-
out using primer IDs, the alleles are in a background of 
PCR and sequencing errors and so there is no ability to 
distinguish background from actual genetic polymor-
phism or to infer the correct population structure due to 
resampling artifacts. These results highlight not only that 
detection of linkage among rare variants is hampered in 
LP-PCR-1, 2 or 3 methods from in  vitro recombination 
in the early cycles of PCR, but that the uSGS method can 
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Fig. 4 Analysis of HIV-1 population structure in a clinical sample using uSGS for library construction. Neighbor joining trees of HIV-1 pol sequence 
from donor 1 sample 1 and blow up of NJ subtree, showing clustering and linkage of WT at RT position 106 (V106V blue squares) with 101Q (blue 
square with black outline). Numbers of identical sequences are shown in parentheses as this NJ tree was extracted from 1585 unique SGS, where 
identical sequences were collapsed. Within the highlighted subtree, note especially two sequences (2) in which WT RT codon 106, and rare muta-
tions 101Q and 108I (blue square with black and orange out line) were found to be linked. Detection of such a rare linkage event would be virtually 
impossible using LP-PCR or conventional SGS. Data were obtained by NGS uSGS and rooted on Consensus B
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correct this deficiency. For this reason, we developed a 
method of library preparation for targeted NGS of HIV-1 
RNA, which results in very low early cycle PCR-recom-
bination and more complete sampling of cDNA libraries. 
Combined with a more stringent bioinformatics pipeline 
for filtering out early PCR errors, this approach results 
in datasets that are virtually free of PCR error and PCR 
recombination. Consequently, our uSGS methodology 
is the most effective means for studying HIV-1 popula-
tion structure as well as for detecting linkage among rare 
alleles. Critical features of this methodology include (1) 
amplification of primer ID-tagged cDNA molecules using 
short primers and a more robust DNA polymerase that 
catalyzes PCR uniformly and efficiently [28] and (2) crea-
tion of 17 base 3′ overhangs at both ends of the amplicons 
to promote highly efficient ligation of linkers contain-
ing NGS adaptors [22, 23], which eliminates the need 
for a subsequent PCR amplification step. Other proto-
cols requiring that NGS adapters be attached to dsDNA 
libraries by blunt-end or nearly blunt-end ligation, (i.e., 
via single nucleotide 3′ overhangs) or in vitro transposi-
tion (Nextera®) are relatively inefficient [29]. Only small 
fractions of amplicons are successfully appended in these 
reactions, necessitating subsequent rounds of PCR prior 
to sequencing [3, 29], likely resulting in amplification 
bias.
As previously reported, mutation arising in primer IDs 
during PCR amplification have the potential to gener-
ate artifacts during NGS library production [15–19]. To 
address this issue, we have also included in our analysis 
pipeline methods developed by Zhou et al. [19] that iden-
tify and exclude such false primer IDs. These tools allow 
us to employ primer IDs without being misled by arti-
facts produced during library amplification.
In conclusion, the uSGS method for targeted, massively 
parallel sequencing of HIV-1 RNA-derived cDNA librar-
ies (1) results in a higher fraction of cDNAs being ampli-
fied and sequenced and (2) virtually eliminates in  vitro 
recombination and PCR error, resulting in hundreds to 
thousands of single-genome HIV-1 sequences that accu-
rately reflect the population genetics of the parent RNA. 
This method can also be used to determine linkage of low 
frequency HIV-1 drug resistance mutations and can be 
modified to assess RNA populations of other viruses or 
expressed host genes.
Methods
RNA preparation and cDNA synthesis
Mixtures of WT and multidrug resistant mutant HIV-1 
BH10 pol RNA transcripts were derived from cloned viral 
DNA as previously described by Shao et al. [2]. An 895-
bp region of HIV-1 BH10 WT and mutant transcripts 
containing codons 22–291 in HIV-1 pol was used for 
controls. Mixtures of WT and multidrug resistant tran-
scripts containing 10 well characterized drug resistance 
mutations, distributed along the 546nt fragment, were 
used for analyzing in  vitro recombination. Viral RNA 
from donor plasma was extracted as described previously 
and placed on ice [30]. RNAs were reverse transcribed in 
50 μL reactions that included 30 nM final concentration 
of HIV-1 gene specific primer with Primer ID (GSPID 
2834R), 500  μM dNTPs (Promega C1145), 1× First 
Strand Buffer, 1 mm DTT, 20 U RNase out (Promega Cat 
#N2115; 40 U/µl) and 200 U SuperScript III (Life Tech-
nologies, Cat #18080-044; 200 U/µl). Oligonucleotide 
sequences are provided in the “Appendix”.
Reverse transcription reactions were incubated at 
45  °C for 1 h and quenched to 4  °C. 60 units of Exonu-
clease 1 (NEB: Cat #M0293S), and 1U Shrimp Alkaline 
Phosphatase (NEB: Cat #M0371S) were added and incu-
bated as follows: 37 °C for 30 min and 85 °C for 15 min. 
5 units of RNase H (NEB: Cat #M0297S) were added 
Table 5 Frequency of  resistance mutations in  donors fail-
ing anti-retroviral therapy as measured by uSGS
Allele Donor 1 Sample 1
% Frequency
(1585 uSGS)
Donor 1 Sample 2
% Frequency
(675 uSGS)
Donor 2 Sample 3
% Frequency
1227 (uSGS)
D67N 100 99.85 99.92
T69A <0.06 0.15 0.08
T69I 0.06 <0.15 <0.08
K70N <0.06 <0.15 0.08
K70Q <0.06 <0.15 1.07
K70T <0.06 <0.15 1.23
L74I <0.06 <0.15 0.08
K101E 95.56 95.72 <0.08
K101Q 4.12 3.99 0.08
K101R <0.06 <0.15 0.49
V106I 91.12 91.58 0.33
V108A <0.06 <0.15 0.08
V108I 0.51 <0.15 0.41
M184I <0.06 <0.15 0.16
M184V <0.06 <0.15 99.84
Y188C 0.06 <0.15 <0.08
G190A 99.81 100 <0.08
G190E <0.06 <0.15 0.08
G190R <0.06 <0.15 0.08
G190T 0.13 <0.15 <0.08
T215F 0.06 <0.15 <0.08
T215R <0.06 <0.15 <0.08
T215Y 99.94 100 100
K219R 99.94 99.85 <0.08
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and incubated for 20  min at 37  and 85  °C for 15  min. 
The cDNA was precipitated overnight at −20  °C with 
0.1 volume (v) 3 M Sodum Acetate, pH 5.5, 20 µg glyco-
gen (Roche: Cat #1090139300) and 3v 95% ETOH. The 
washed and dried precipitated cDNA was suspended in 
5 mM Tris–HCl, pH 8.0 and processed reserving 5 µl for 
quantification by qPCR.
cDNA amplification in uSGS
Five replicate 25 µl PCR reactions were performed for the 
first round of PCR with final concentrations as follows: 
1× Kapa Hi Fi Hot Start Uracil +reaction mix (KAPABI-
OSYTEMS Cat #KK2802), 300 nM forward primer #28F 
(2195), 300  nM dU-containing reverse primer PrimRe-
gion-R-5Us and cycled as follows: 1 cycle 95 °C for 3 min, 
Table 6 Linkage of resistance mutations in donors failing anti-retroviral therapy as measured by uSGS
Patient/sample Haplotypes
Mutant codons in italics
Expected (%) Observed (%) P value
1/1 67N, 69T, 101E, 106I, 108V, 188Y, 190A, 215F, 219R 0.05 0.06 0.58
67N, 69T, 101Q, 106V, 108I, 188Y, 190A, 215Y, 219R 0.002 0.13 0.0004
67N, 69T, 101E,106V,108V,188Y,190A,215Y,219R 8.41 5.58 1.18*10−5
67N,69T,101E,106V,108I,188Y,190A,215Y,219R 0.04 0.06 0.49
67N,69T,101Q,106V,108V,188Y,190A,215Y,219R 0.36 3.04 1.0*10−237
67N,69T,101Q,106V,108V,188Y,190G,215Y,219R 0.0002 0.06 0.004
67N, 69T, 101E, 106I, 108I, 188Y, 190A, 215Y, 219R 0.44 0.25 0.18
67N, 69T, 101E, 106I, 108V, 188Y, 190T, 215Y, 219R 0.11 0.13 0.52
67N, 69T, 101E, 106I, 108V, 188Y, 190A,215Y, 219R 86.25 89.22 0.0003
67N, 69T, 101E, 106I, 108V, 188Y, 190A, 215Y, 219K 0.05 0.06 0.58
67N, 69T, 101K, 106I, 108V, 188Y, 190A, 215Y, 219R 0.34 0.38 0.46
67N, 69T, 101Q, 106I, 108V, 188Y, 190A, 215Y, 219R 3.72 0.82 3.1*10−13
67N, 69I, 101E, 106I, 108V, 188Y, 190A, 215Y, 219R 0.05 0.06 0.58
67N, 69T, 101E, 106I, 108V, 188C, 190A, 215Y, 219R 0.05 0.06 0.58
67N, 69T, 101Q, 106I, 108I, 188Y, 190A, 215Y, 219R 0.02 0.06 0.26
1/2 67N, 69T, 101E, 106I, 190A, 215Y, 219K 0.13 0.15 0.58
67N, 69T, 101K, 106V, 190A, 215Y, 219R 0.02 0.15 0.15
67D, 69T, 101E, 106V, 190A, 215Y, 219R 0.01 0.15 0.08
67N, 69T, 101E, 106I, 190A, 215Y, 219R 87.42 90.25 0.01
67N, 69T, 101Q, 106V, 190A, 215Y, 219R 0.33 3.10 5.1*10−14
67N, 69T, 101K, 106I, 190A, 215Y, 219R 0.27 0.15 0.45
67N, 69T, 101E, 106V, 190A, 215Y, 219R 8.04 5.02 0.001
67N, 69A, 101E, 106I, 190A, 215Y, 219R 0.13 0.15 0.58
67N, 69T, 101Q, 106I, 190A, 215Y, 219R 3.64 0.89 6.1*10−6
2/3 67N, 69T, 70Q, 74L, 101K, 106V, 108V, 184V, 190G, 215Y 1.05 1.07 0.51
67N, 69T, 70K, 74L, 101R, 106V, 108V, 184V, 190G, 215Y 0.48 0.49 0.52
67N, 69T, 70K, 74L, 101K, 106V, 108V, 184I, 190G, 215Y 0.16 0.16 0.57
67D, 69T, 70K, 74L, 101K, 106V, 108V, 184V, 190G, 215Y 0.08 0.08 0.62
67N.69T, 70K, 74L, 101K, 106I, 108V, 184V, 190G, 215Y 0.32 0.33 0.54
67N, 69T, 70K, 74L, 101K, 106V, 108V, 184V, 190E, 215Y 0.08 0.08 0.62
67N 69T, 70K, 74L, 101K, 106V, 108V, 184V, 190R, 215Y 0.08 0.08 0.62
67N, 69T, 70K, 74I, 101K, 106V, 108V, 184V, 190G, 215Y 0.08 0.08 0.62
67N 69A, 70K, 74L, 101K, 106V, 108V, 184V, 190G, 215Y 0.08 0.08 0.62
67N, 69T, 70N, 74L, 101K, 106V, 108V, 184V, 190G, 215Y 0.08 0.08 0.63
67N 69T, 70T, 74L, 101K, 106V, 108V, 184V, 190G, 215Y 1.21 1.23 0.51
67N, 69T, 70K, 74L, 101Q, 106V, 108V184V, 190G, 215Y 0.08 0.08 0.62
67N 69T, 70K, 74L101K, 106V, 108V, 184V, 190G, 215Y 95.76 95.64 0.44
67N 69T, 70K, 74L, 101K, 106V, 108A, 184V, 190G, 215Y 0.08 0.08 0.62
67N, 69T, 70K, 74L, 101K, 106V, 108I, 184V, 190G, 215Y 0.40 0.41 0.53
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10 cycles 95 °C for 20 s, 60 °C for 30 s, 68  for 2 min with 
5 s added onto each subsequent cycle. The products from 
all 5 reactions belonging to the same sample were com-
bined and purified using the Mini Elute PCR purification 
kit from Qiagen (Cat #28004). A second round of PCR 
was performed exactly as the first except the entire puri-
fied product from the first PCR was used as template in 
5 replicate reactions with final concentrations of 300 nM 
primers of forward primer 2286-F-dUs and reverse 
primer PrimRegion-R-5Us and cycled 20–30 times. The 
products from all 5 reactions belonging to the same sam-
ple are combined and PCR purified using the QIAquick 
PCR Purification Kit from Qiagen (Cat #28104).
Processing of DNA termini and adapter ligation in uSGS
In 50  μl reactions, PCR products generated using dU-
containing primers were treated with 10 units of uracil-
DNA glycosylase (UDG) (NEB M0280S) and incubated 
for 2  h at 37  °C. This enzyme hydrolyzes the glycosidic 
bonds in 2′-deoxyuridines, thereby releasing the uracil 
bases and generating chemically labile abasic sites at the 
affected positions. The UDG-treated DNA was cleaved 
at these abasic sites with 2 N NaOH at a final concentra-
tion of 0.25 N and incubated at 65  °C for 30 min. Solu-
tions were neutralized by adding an equimolar amount 
of 2 M Trizma Hydrochloride. DNAs were renatured by 
heating to 85 °C for 2 min, and slow cooled at 0.1 °C/s to 
25 °C. The dsDNA was precipitated overnight at −20 °C 
with 0.1v 3  M Sodium Acetate, pH 5.5, 20  µg glycogen 
and 3v 95% ETOH. Collectively, these treatments gener-
ated a double-stranded DNA library in which amplicons 
contained distinct 17 nt 3′ overhangs at both ends. These 
sticky ends were complementary to the NGS adapters 
(Linker F1 and Linker R2), facilitating their attachment 
to the hydrolyzed DNA strands by bridging ligation – a 
process much more efficient than blunt end ligation or 
ligation utilizing a single nucleotide overhang, avoiding 
inefficient ligation and the necessity for additional cycles 
of PCR.
The method was completed by hybridizing NGS linkers 
to the 17-nt 3′ overhangs using ~2 pmol DNA, 1× NEB 
buffer #2, 4 pmol linker F, 4 pmol linker R and 1 mM final 
concentration of ATP (NEB Cat #P0756S). The reactions 
were heated to 65 °C for 5 min and slow cooled at 0.1 °C/s 
to 25 °C. 400 units of T4 DNA ligase (NEB Cat #M0202S) 
was added and incubated at 25  °C for 16  h (overnight), 
and then heated to 65  °C for 10  min. The 5′ overhangs 
were filled in with 5 units of Klenow Fragment DNA 
polymerase (NEB Cat #M0212S) and 400 µM dNTPs and 
incubated at 37 °C for 2 h.
Ligation reactions were resolved on a 1.5% agarose gel 
and the ~719 bp fragment was excised and purified using 
Qiagen Qiaquick Gel Extraction kit Cat #28704.
Each sample was quantified using the KAPA SYBR 
FAST universal qPCR kit (KK4824 KAPA Biosystems) by 
following manufacturer’s directions. Samples were nor-
malized to 2  nM combined and loaded for paired-end 
sequencing using the Illumina Miseq.
cDNA amplification in LP-PCR-1
Five replicate 25  µl PCR reactions were performed for 
LP-PCR-1 with final concentrations of 1× SYBR green 
buffer, 4  mM MgCl2, 500  µM dNTPs, 5U AmpliTaq 
Gold and 300  nM each MiSeq forward primer I and 
MiSeq reverse primer 2. All reactions were performed 
using the following cycling conditions: 1 cycle 95  °C 
for 10 min, 10 cycles 95  °C for 30  s, 53  °C for 30  s, 72   
for 2 min, then 45 cycles of 95 °C for 30 s, 72 °C 2 min. 
Following PCR, the 5 reactions were combined and gel 
purified using a Qiaquick gel extraction kit as per man-
ufacturer’s protocol. Samples were quantified following 
manufacturer’s protocol using a Kapa Library Quantifi-
cation kit.
cDNA amplification in LP-PCR-2
This protocol was adapted from Zhou et  al. [19] and 
was essentially 2 rounds of 25 cycle flanking PCR using 
oligos of 50 and 54 nt in length for the first round and 
58 and 61 nt for the flanking round 2. In short, 5 repli-
cate 25 µl PCR reactions were performed for LP-PCR-2, 
round 1 with final concentrations of 1× Robust KapaG2 
mix (Kapa Biosystems) and 200 nM forward primer B2F 
and reverse B6R and cycled as follows: 1 cycle of 95° 
1 min, 25 cycles of 95 °C 15 s, 58 °C1 min and 72 °C 30 s 
and 1 cycle of 72 °C for 3 min. PCR products were PCR 
purified using the QIAquick PCR Purification Kit from 
Qiagen and 2 µl (of the 50 µl eluted) used as template in 
a second round of PCR. Round 2 was performed exactly 
as round 1 except forward primer B6F and reverse B7R 
were used. All reactions were performed using the same 
cycling conditions as in round 1.
cDNA amplification in LP-PCR-3
This protocol was adapted from Seifert et  al. [20] and 
comprised 3 rounds of PCR. The first round used short 
oligos of 25–31 nt in length in 30 cycles of PCR, the sec-
ond used 30 cycles of flanking PCR using oligos of 50 
and 54 nt long and the third used 12 cycles of flanking 
PCR using oligos of 58 and 61 nt in length. In short, 5 
replicate 25  µl PCR reactions were performed for LP-
PCR-3 round 1 with final concentrations of 1× Platinum 
taq buffer, 400 µM dNTPs, 2 mM MgSO4, and 200 nM 
forward primer #28F (2195), 200  nM reverse primer 
PrimRegion-R (the same primers used in uSGS round 
1) and cycled as follows: 95 °C 2 min, 30 cycles at 95 °C 
15 s, 53 °C 30 s, 68 °C 1 min. PCR products were diluted 
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to ~100,000 copies (as measured by qPCR) and used as 
template in a semi nested PCR round 2. Round 2 was 
performed exactly as round 1 except forward primer 
B1F and reverse B4R were used. A third round of PCR 
was performed following purification of the products 
and 1 ng used as template in 12 additional cycles of PCR 
using forward primer B6F and reverse B7R and Jump-
Start Taq ready mix (Sigma-Aldrich P2893) and cycled 
as follows: 95  °C 2  min, 12 cycles of 95  °C 30  s, 53  °C 
30 s, 72 °C 1 min. The 5 reactions were combined and gel 
purified using a Qiaquick gel extraction kit as per manu-
facture’s protocol. Samples were quantified following 
manufacture’s protocol using Kapa Library Quantifica-
tion kit.
MiSeq sequencing and analyses
Samples were prepared for Miseq Illumina sequencing 
as directed in the protocol for the 500-cycle MiSeq v2 kit 
(MS-102-2003 Illumina Inc, San Diego, CA). A final con-
centration of  ~10  pM of the pooled sample was spiked 
with 20% of the PhiX DNA control. After the Miseq runs 
were complete, Fastq files were exported for bioinformat-
ics analyses. The MiSeq paired-end reads were concat-
enated (the reverse complement sequence was used for 
read 2). Low quality reads were removed using a program 
available at http://hannonlab.cshl.edu/fastx_toolkit (with 
parameters −Q20 –P90, and default for all other settings). 
The filtered fastq sequences were then converted to fasta 
format and the fasta reads were sorted by barcodes using 
programs available on the same website. The reads were 
then compared to a reference sequence and the primer 
IDs were determined using an in-house Perl script. Primer 
IDs containing indels were discarded. Reads with identical 
primer IDs were grouped for consensus or super-majority 
(≥80% identity at each site) construction. The minimum 
number of raw sequences for consensus construction 
was determined by the Zhou et al. [19] cutoff model. All 
primer ID groups smaller than this cutoff were discarded. 
For the purpose of comparing the methods presented in 
this manuscript, super-majority sequences containing 
ambiguous bases were retained. However, for analysis 
of clinical samples, the presence of more than one such 
base resulted in exclusion of that sequence from the data-
set, essentially omitting the in  vitro PCR recombinants 
from the final data. An in-house Perl script was used to 
determine the allele frequencies at each position. Neigh-
bor-joining trees were constructed using Mega 6 [31]. 
Probabilities for the expected vs. observed haplotypes 
were determined with Hardy–Weinberg statistics. Miseq 
data will be made available in GenBank. Perl scripts used 
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28-2195F  5′ AAACAATGGCCATTGACAGAAG 
A 3′
2286-F-dUs  5′ CdUGAAAAdUCCAdUACAAdUAC 
TCCAGTATTTGC 3′
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PrimRegion-R-5Us  5′ GGdUAdUCGAAGdUCAdU 
CCdUGCTAG 3′

































Long primer PCR-3 primers
First round
28-2195F  5′ AAACAATGGCCATTGAC 
AGAAGA 3′

















qPCR 24F  5′ AATACTCCAGTATTTGCCATAA 
3′
qPCR 23R:  5′ TCCCCACCTCAACAGATGTT 3′
Indexes are underlined in the primer or linker sequences 
shown and are changed for every sample. Only examples 
are shown here, however, standard indexes used in MiSeq 
experiments are provided by Illumina, Inc. 9885 Towne 
Centre Drive San Diego, CA 92121 (www.illumina.com). 
We advise varying indexes in consecutive experiments so 
that cross-contamination may be readily detected.
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